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Edited by Masayuki MiyasakaAbstract Macrophage clearance of dying cells is of crucial
importance to maintain tissue homeostasis. Here, we show that
brief treatment (15 min) of Jurkat T cells with agonistic anti-
Fas antibodies or recombinant Fas ligand results in eﬃcient
phagocytosis by human monocyte-derived macrophages prior to
the occurrence of common biomarkers of apoptosis. Similar ﬁnd-
ings were obtained when using primary human T cells. Macro-
phage engulfment of pre-apoptotic target cells was suppressed in
the absence of serum. Moreover, pre-apoptotic cells secreted an-
nexin I and administration of Boc1, a formyl peptide receptor/lip-
oxin receptor antagonist markedly attenuated their engulfment.
Finally, pre-apoptotic Jurkat cells induced lower macrophage
production of tumor necrosis factor-a and higher production of
interleukin-10 in comparison to apoptotic target cells.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Clearance of apoptotic cells by macrophages or other
phagocytes has numerous important immunological conse-
quences and serves to encode ‘‘meaning’’ into the process of
cell death [1]. The most well-studied surface change occurring
during apoptosis is the loss of plasma membrane phospholipid
asymmetry with the concomitant externalization of the recog-
nition signal, phosphatidylserine (PS) [2]. However, recent
studies have indicated that cell surface exposition of proteins,
including annexin I, also can function as recognition signals
for macrophages [3]. Moreover, pioneering studies suggested
the involvement of carbohydrates in macrophage disposal of
apoptotic cells [4]. Indeed, ligation of the death receptor,
Fas/APO-1 (CD95) on the surface of Jurkat T cells has been
shown to result in recognition of these cells by macrophagesAbbreviations: CTL, cytotoxic T lymphocytes; DAPI, 4 0-6-diamidino-
2-phenylindole; DEVD-AMC, aspartate–glutamate–valine–aspartate-
7-amino-4-methyl-coumarin; FBS, fetal bovine serum; FPRL-1,
formyl-peptide receptor-like-1; HMDM, human monocyte-derived
macrophages; IL, interleukin; M-CSF, macrophage colony-stimulating
factor; PARP, poly(ADP-ribose) polymerase; PS, phosphatidylserine;
TAMRA, 5(6)-carboxytetramethyl-rhodamine N-hydroxy-succimide
ester; TNF-a, tumor necrosis factor-a; zVAD-fmk, benzyloxycar-
bonyl–valine–alanine–aspartate–ﬂuoromethylketone
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doi:10.1016/j.febslet.2008.09.020through clusters of carbohydrate chains [5]. Subsequent work
indicated that anti-Fas antibody-triggered target cells are sus-
ceptible to macrophage removal at an early stage of apoptosis
by the carbohydrate-mediated mechanism, and at a later stage
by a PS-dependent mechanism [6].
We have previously demonstrated that engulfment of Fas/
APO-1-triggered target cells is dependent upon PS oxidation
and externalization [7]. Jurkat T cells were subjected to 2–4 h
ligation of Fas/APO-1 with agonistic antibodies in the latter
studies, because optimal apoptosis induction is known to occur
at these time-points [8]. Here, we tested whether brief cross-
linking (15 min) of Fas/APO-1 on Jurkat T cells or primary
human T cells renders these cells appetizing to human mono-
cyte-derived macrophages.2. Materials and methods
2.1. Reagents
Agonistic (clone CH-11) (IgM) and antagonistic (clone ZB4) (IgG1)
anti-Fas monoclonal antibodies were purchased from Medical and
Biological Laboratories, Ltd. (Nagoya, Japan). Recombinant human
Fas ligand (SuperFasLigand) was obtained from Alexis Biochemicals
(San Diego, CA). z-VAD-fmk (benzyloxycarbonyl–valine–alanine–
aspartate–ﬂuoromethylketone) was purchased from Enzyme Systems
Products (Dublin, CA) and DEVD-AMC (aspartate–glutamate–va-
line–aspartate–7-amino-4-methyl-coumarin) was from Peptide Insti-
tute Inc. (Osaka, Japan). 4 0-6-Diamidino-2-phenylindole (DAPI) and
Boc1 (N-t-Boc-Phe-D-Leu-Phe-D-Leu-Phe) were from Vector Labora-
tories (Burlingame, CA) and MP Biomedicals (Illkirch, France),
respectively.
2.2. Jurkat cell culture
Human Jurkat T lymphoblastic leukemia cells (European Cell Cul-
ture Collection, Salisbury, UK) were grown in RPMI-1640 medium
supplemented with 10% heat-inactivated fetal bovine serum (FBS),
2 mM glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin
(Life Technologies).
2.3. T cell isolation and culture
Peripheral blood mononuclear cells were isolated from heparinized
blood obtained from healthy adult donors by density gradient centri-
fugation (Lymphoprep, Nycomed Pharma AS, Oslo, Norway). After
separation, cells were cultured in RPMI-1640 medium supplemented
with 10% heat-inactivated FBS, 2 mM glutamine, 100 U/ml penicillin,
and 100 mg/ml streptomycin. Cells were activated for 2 days in the
presence of phytohaemagglutinin (PHA) (5 lg/ml) (Sigma, St. Louis,
MO) and then cultured for 24 h with recombinant IL-2 (50 IU/ml)
(Roche Diagnostics Scandinavia AB, Bromma, Sweden) prior to
Fas/APO-1 cross-linking experiments.
2.4. Human macrophage isolation and culture
Monocytes were prepared from buﬀy coats obtained from adult
blood donors as described before [7]. Cells were grown in RPMI-
1640 medium supplemented with 10% heat-inactivated FBS, 2 mMblished by Elsevier B.V. All rights reserved.
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ate activated macrophages, human monocyte-derived macrophages
(HMDM) were cultured for 3 days in the presence of recombinant
macrophage colony-stimulating factor (M-CSF) (50 ng/ml) (R&D Sys-
tems, Minneapolis, MN).
2.5. Caspase-3-like enzyme activity
The measurement of DEVD-AMC cleavage was performed in a
ﬂuorometric assay as previously described [9]. Cleavage of the ﬂuoro-
genic peptide substrate, DEVD-AMC (50 mM) was monitored by
AMC liberation using a Fluoroscan II plate reader (Labsystems,
Stockholm, Sweden). Real-time recordings of AMC ﬂuorescence were
performed during a 30 min period and results are reported as pmol
AMC release/min.
2.6. PS externalization
PS exposure was determined using the annexin V-FITC apoptosis
detection kit (Oncogene Research Products, Cambridge, MA). Cells
were co-stained with propidium iodide (50 lg/ml) before analysis with
a FACScan ﬂow cytometer (BD Biosciences, San Jose, CA) equipped
with a 488-nm argon laser. Ten thousand events were collected and
analyzed using the CellQuest software (BD Biosciences). Cell debris
was gated out prior to analysis based on light scattering properties.
2.7. Annexin I surface expression
Cells were harvested and resuspended in antibody-binding buﬀer
(10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2; pH 7.4) containing
either rabbit anti-human annexin I antibodies (Zymed Laboratories,
San Fransisco, CA) or negative control antibodies (DAKO, Glostrup,A
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Fig. 1. Kinetics of PS exposure and caspase activation following Fas/APO
(250 ng/ml) for the indicated time-points and caspase-3-like enzyme activity
Western blotting using a speciﬁc antibody that recognizes the large fragmen
Jurkat cells were incubated with anti-Fas antibody for the indicated time-poin
related fragment using a speciﬁc anti-PARP antibody. Jurkat cells were treate
30 min with z-VAD-fmk (10 lM) were incubated with anti-Fas antibody an
three independent experiments.Denmark). Cells were then incubated with secondary FITC-conjugated
swine anti-rabbit polyclonal antibodies (DAKO) and samples were
analyzed on a FACScan ﬂow cytometer (BD Biosciences).
2.8. Western blot analysis
Equal volumes of supernatants from cell cultures (annexin I), or
equal amounts of protein (30 lg) (caspase-3, PARP), were resolved
by electrophoresis on a 12% SDS–polyacrylamide gel and transferred
to polyvinylidene diﬂuoride membranes (Bio-Rad Laboratories, Her-
cules, CA). The membranes were incubated with blocking buﬀer con-
taining 0.1% Tween-20 and 5% skimmed milk and probed with rabbit
anti-caspase-3 (Asp175) antibody (Cell Signaling Technology, Dan-
vers, MA), mouse anti-PARP antibody (BIOMOL International,
Plymouth Meeting, PA), or rabbit anti-annexin I antibody (Zymed
Laboratories). Following incubation with horseradish peroxidase-con-
jugated anti-rabbit or anti-mouse secondary antibodies (DAKO),
bound antibody was visualized with enhanced chemiluminescence
(GE Healthcare, Buckinghamshire, UK).
2.9. Phagocytosis assays
Macrophage engulfment of target cells was determined essentially as
described previously [7]. In brief, Jurkat cells or primary T cells were
pre-stained with 5(6)-carboxytetramethyl-rhodamine N-hydroxy-succi-
mide ester (TAMRA) (Sigma) and incubated in the presence or ab-
sence of anti-Fas antibody or recombinant Fas ligand. Cells were
subsequently added to HMDM in 24-well tissue culture plates at a ra-
tio of 5:1. Following co-cultivation for 1 h, non-engulfed cells were
washed oﬀ and the remaining cells were ﬁxed in 4% paraformaldehyde.
Phagocytosis was evaluated by counting at least 500 macrophages in1 h 2 h 4 h
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S. Zhang et al. / FEBS Letters 582 (2008) 3501–3508 3503visual light and thereafter counting macrophage-engulfed cells under
UV illumination using an inverted Nikon ECLIPSE TE2000-S ﬂuores-
cence microscope (Nikon Corporation, Kanagawa, Japan) equipped
with a Nikon Digital Sight DS-U2 camera and operating with NIS-
Elements F software (Nikon Corporation).
2.10. Cytokine secretion
Cell culture supernatants were harvested and cells and cell debris were
cleared by centrifugation at 1000 rpm and 13000 rpm, respectively. Tu-
mor necrosis factor-a (TNF-a) and interleukin-10 (IL-10)-10 levels were
measured with the Cytometric Bead Array (CBA) kit (BD Biosciences)
and the analysis was carried out using a FACScalibur ﬂow cytometer
(Becton Dickinson) and the CBA software (BD Biosciences).3. Results
3.1. Kinetics of apoptosis triggered by antibody-mediated Fas/
APO-1 cross-linking
Monoclonal IgM anti-Fas antibodies [10] were used to cross-
link Fas/APO-1 on the surface of Jurkat cells. This resulted inC
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Fig. 2. Phagocytosis of pre-apoptotic Jurkat target cells. Jurkat cells were tr
points and co-cultivated with HMDM. Phagocytosis is reported as percenta
numbers of engulfed target cells per macrophage (B). The data are expressed
phagocytosis of TAMRA-labeled Jurkat target cells (red). Nuclei of macropa time-dependent increase in apoptosis, with caspase activation
(Fig. 1A and B), cleavage of PARP (Fig. 1C), and PS external-
ization (Fig. 1D) starting at approx. 2 h of cross-linking. PS
externalization was eﬀectively blocked by the pan-caspase
inhibitor, z-VAD-fmk, in line with our previous observations
[7]. Treatment of Jurkat cells with agonistic anti-Fas antibod-
ies for longer than 4 h resulted in secondary necrosis (data not
shown).
3.2. Phagocytosis of pre-apoptotic cells by activated human
macrophages
Next, we cross-linked Fas/APO-1 for various time-points
ranging from 15 min to 4 h and co-cultivated the Jurkat cells
with M-CSF-stimulated HMDM. As seen in Fig. 2A, approx.
60% of the HMDM were positive for engulfment of apoptotic
Jurkat cells following 1 h of co-culture. Strikingly, pre-apopto-
tic cells were also engulfed with similar eﬃciency by profes-
sional phagocytes, both in terms of the number of
phagocytosis-positive HMDM (Fig. 2A) and the number of0
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bation of Jurkat cells with the antagonistic anti-Fas antibody
(IgG1) [11] failed to promote engulfment (data not shown).
Representative images of HMDM engulfment of pre-apoptotic
versus apoptotic target cells are shown in Fig. 2C. To verify
our ﬁndings in another cell type, primary human T cells from
peripheral blood were subjected to treatment with agonistic
anti-Fas antibodies for various time-points, and PS external-
ization and phagocytosis by HMDM was monitored. Primary
T cells were eﬀectively engulfed upon brief (15 min) cross-link-
ing of Fas/APO-1 and the degree of phagocytosis was compa-
rable after 6 h of cross-linking (Fig. 3A and B). PS
externalization, however, was not evident at 15 min of treat-
ment and was detected only at prolonged (6 h or longer) treat-
ment with agonistic anti-Fas antibodies (data not shown).
3.3. Phagocytosis of target cells following brief stimulation with
recombinant Fas ligand
To test whether the phenomenon of engulfment of pre-apop-
totic target cells was restricted to anti-Fas antibody-mediated
cross-linking, Jurkat cells were incubated instead with recom-
binant human Fas ligand at concentrations shown in pilot
studies to trigger caspase activation at 4 h (data not shown).
Time-course studies of Fas ligand-treated cells showed that
PS externalization occurred at approx. 2 h, albeit to a lesser ex-
tent as compared to anti-Fas antibody-treated cells (Fig. 4A).
PS externalization was blocked by zVAD-fmk. Notably, pre-
apoptotic (PS-negative) and apoptotic (PS-positive) target cells
were engulfed to a similar extent by activated HMDM(Fig. 4B), thus supporting our ﬁndings obtained using agonis-
tic anti-Fas antibodies.
3.4. Serum-dependent phagocytosis of apoptotic and
pre-apoptotic cells
To investigate the possible role of serum factors for engulf-
ment, the cell culture medium containing 10% fetal bovine
serum (FBS) was substituted with serum-deprived medium
(0% FBS) during the 1 h co-cultivation of target cells with
HMDM. Complete serum deprivation inhibited phagocytosis
of pre-apoptotic and apoptotic Jurkat target cells by approx.
80% and 40%, respectively (Fig. 5A). Macrophage viability
was not aﬀected by serum deprivation. Partial repletion of
serum (1% FBS) resulted in complete recovery of phagocyto-
sis of both pre-apoptotic and apoptotic cells (data not
shown).
3.5. Role of caspase activity for phagocytosis of pre-apoptotic
cells
To further examine the role of caspases, phagocytosis was
assessed in the presence or absence of z-VAD-fmk. As shown
in Fig. 5B, pre-treatment of target cells with the pan-caspase
inhibitor prior to co-cultivation with HMDM had no eﬀect
on the engulfment of pre-apoptotic target cells whereas the
engulfment of apoptotic target cells was signiﬁcantly reduced.
However, addition of zVAD-fmk to the co-culture system par-
tially suppressed macrophage engulfment of pre-apoptotic
cells and further decreased the engulfment of apoptotic cells
(Fig. 5B).
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S. Zhang et al. / FEBS Letters 582 (2008) 3501–3508 35053.6. Role of annexin I in phagocytosis of pre-apoptotic cells
Externalization of annexin I has been suggested to play an
important role in programmed cell clearance [3]. We therefore
investigated whether annexin I translocates to the cell surface
upon ligation of Fas/APO-1. As shown in Fig. 6A, the kinetics
of annexin I externalization following treatment with anti-Fas
IgM antibodies appeared to parallel the kinetics of PS exter-
nalization. In addition, externalization of both annexin I and
PS following cross-linking of Fas/APO-1 (4 h) increased in
the absence of serum (data not shown). Annexin I was recently
shown to be released from apoptotic cells [12]. Of note, immu-
noblotting of conditioned medium obtained from co-cultures
of phagocytes and pre-apoptotic as well as apoptotic target
cells revealed the presence of annexin I (37 kDa) and a shorter
fragment (33 kDa) (Fig. 6B). To elucidate whether macro-
phages or target cells are the source of secreted annexin I,
we examined supernatants of Jurkat cells alone following incu-
bation with agonistic anti-Fas antibodies. As seen in Fig. 6C,
Jurkat cells released signiﬁcant amounts of annexin I as early
as 15 min after Fas/APO-1 ligation. To determine the role of
annexin I secretion for HMDM engulfment of Fas/APO-1-
triggered Jurkat cells, the formyl-peptide receptor antagonist,
Boc1 [13] was added to the co-cultures. Boc1 inhibited macro-
phage engulfment of pre-apoptotic target cells to a signiﬁcant
extent (approx. 50% reduction of phagocytosis-positive
HMDM) (Fig. 6D).3.7. Cytokine production upon phagocytosis of pre-apoptotic
cells
Finally, macrophage production of IL-10, representative of
anti-inﬂammatory cytokines, and TNF-a, a prominent pro-
inﬂammatory cytokine, upon co-cultivation with target cells
was monitored using speciﬁc antibodies. HMDM co-cultured
with pre-apoptotic Jurkat cells produced low levels of TNF-
a, comparable to macrophages co-cultured with control cells,
while macrophages incubated with apoptotic target cells pro-
duced signiﬁcantly higher levels of TNF-a (Fig. 7A). More-
over, IL-10 production was lower for macrophages co-
cultured with apoptotic Jurkat cells when compared to macro-
phages co-cultured with pre-apoptotic or control cells
(Fig. 7B).4. Discussion
Our studies demonstrate that pre-apoptotic cells may under-
go eﬃcient clearance by activated human macrophages. Of
note, antagonistic anti-Fas antibodies failed to promote
engulfment whereas brief stimulation with agonistic anti-Fas
antibodies and recombinant Fas ligand induced target cell
engulfment, indicating that the clearance of pre-apoptotic cells
is not related to a non-speciﬁc, antibody-dependent opsonisa-
tion. Previous investigations of Fas/APO-1-mediated apopto-
A B
0
10
20
30
40
50
60
70
80
90
100
0 min 15 min 4 h
Anti-Fas IgM treatment
Ph
ag
oc
yt
os
is-
po
sit
ive
 H
M
D
M
 (%
)
10% FBS
0% FBS
0
10
20
30
40
50
60
70
0 min 15 min 4 h
Anti-Fas IgM treatment
Ph
ag
oc
yt
os
is-
po
sit
ive
 H
M
D
M
 (%
)
Control
z-VAD-fmk +
z-VAD-fmk ++
*
* ***
**
Fig. 5. Pre-apoptotic cell engulfment: eﬀects of serum deprivation and caspase inhibition. (A) Jurkat cells were treated with anti-Fas antibody for
15 min or 4 h and then co-cultivated with HMDM. The co-culture was performed with or without addition of 10% FBS. Data are shown as mean
values ± S.D. (n = 3). **P < 0.005. (B) Jurkat cells were pre-treated or not with z-VAD-fmk (10 lM) for 30 min before the addition of anti-Fas
antibody and then co-cultivated with HMDM (z-VAD-fmk +). Alternatively, Jurkat cells were pre-treated with z-VAD-fmk for 30 min prior to Fas/
APO-1 cross-linking, and z-VAD-fmk was also present in the co-culture medium during phagocytosis (z-VAD-fmk ++). Data are shown as mean
values ± S.D. (n = 3). *P < 0.05 (by Students t-test).
A
0 min 15 min 30 min
1 h 2 h 4 h
Annexin I (FITC)
Ce
ll c
ou
n
ts
0
10
20
30
40
50
60
70
0 min 15 min 4 h
Anti-Fas IgM treatment
Ph
a
go
cy
to
si
s-
po
si
tiv
e 
H
M
D
M
 (%
)
D
Control
Boc-1
** *
B
37 kD
33 kD
HM
DM
0 m
in
15
m
in
4
h
Me
diu
m
0 m
in
15
mi
n
30
m
in
1 h 2 h 4 h
C
co-culture
Jurkat
37 kD
33 kD
Fig. 6. Role of annexin I for pre-apoptotic cell engulfment. (A) Kinetics of annexin I externalization on Jurkat cells treated with anti-Fas antibody
(mouse) for the indicated time-points was analyzed by ﬂow cytometry using speciﬁc anti-annexin I antibodies (rabbit) and FITC-conjugated
secondary anti-rabbit antibodies. Filled histograms correspond to isotype-matched negative control antibodies. (B) Annexin I expression in
conditioned medium obtained after co-culture with HMDM and Jurkat target cells. Medium obtained from cultures of HMDM alone is included for
comparison. Membranes were probed with speciﬁc anti-annexin I antibodies. (C) Western blotting of supernatants of Jurkat cells treated with anti-
Fas antibody. Results are representative of several independent experiments. (D) Phagocytosis of Fas/APO-1 cross-linked Jurkat target cells by
HMDM in the presence or absence of the formyl-peptide receptor-like-1 (FPRL-1 antagonist, Boc1 (50 lM). Data shown are mean values ± S.D.
(n = 3). *P < 0.05; **P < 0.01 (by Students t-test).
3506 S. Zhang et al. / FEBS Letters 582 (2008) 3501–3508
AB
TN
F-
α
co
n
ce
n
tra
tio
n 
(pg
/m
l)
0
20
40
60
80
100
120
140
160
180
200
IL
-1
0 
co
nc
en
tra
tio
n 
(pg
/m
l)
0
50
100
150
200
250
300
0 min 15 min 4 h HMDM
*
*
Anti-Fas IgM treatment
Jurkat
0 min 15 min 4 h HMDM
Anti-Fas IgM treatment
Jurkat
Fig. 7. Macrophage production of cytokines. (A) Supernatants
harvested immediately after 1 h of co-culture of HMDM and Jurkat
target cells (treated for the indicated time-points with anti-Fas
antibody; 250 ng/ml) were analyzed for TNF-a expression. Superna-
tants obtained from cultures of HMDM alone and anti-Fas antibody-
treated (4 h) Jurkat cells alone are also shown. (B) Fas/APO-1 cross-
linked Jurkat target cells and HMDM were co-cultivated for 1 h. Un-
engulfed target cells were then washed oﬀ and HMDM were
maintained in fresh medium for 8 h prior to assessment of IL-10
expression in the supernatants. Supernatants of HMDM alone and
anti-Fas antibody-treated Jurkat cells alone are also included. Data in
(A) and (B) are reported as mean values ± S.D. of duplicate samples
from two independent experiments. *P < 0.05 (by Students t-test).
S. Zhang et al. / FEBS Letters 582 (2008) 3501–3508 3507sis have indicated that diﬀerent ‘‘eat-me’’ signals are utilized in
a sequential manner, with carbohydrate-mediated mechanisms
of cell clearance operating during early stages, and PS-depen-
dent mechanisms coming into play at later stages of apoptosis
[6]. The present studies suggest that annexin I may play a role
at very early (pre-apoptotic) stages of programmed cell clear-
ance. However, our ﬁndings do not exclude the potential
involvement of additional recognition signal(s) for macro-
phage engulfment of pre-apoptotic cells. Nevertheless, one
may speculate that clearance of target cells following Fas/
APO-1 cross-linking could depend on the sequential involve-
ment of proteins, sugars, and lipids as recognition signals for
engulﬁng cells. In addition, our studies show that macrophage
clearance of pre-apoptotic displayed a strong dependence on
serum. Identiﬁcation of the serum components necessary for
engulfment of Fas/APO-1-triggered target cells remains an
important area of investigation.
Previous studies have revealed that caspase activation in the
Jurkat cell line is delayed until approx. 1 h after ligation of
Fas/APO-1 [14]. On the other hand, translocation of the p65component of NFjB to the nucleus occurs at 5 min after
cross-linking of Fas/APO-1 [15], indicating that signaling
events are initiated very soon after ligation of Fas/APO-1. In-
deed, our current observations are suggestive of annexin I-
dependent signaling for engulfment following brief (15 min)
cross-linking of Fas/APO-1, prior to the emergence of other
common biomarkers of apoptosis. Cleavage and release of an-
nexin I during apoptosis has been reported in other model sys-
tems [12], and a range of diﬀerent proteases have been shown
to target annexin I in the N-terminal domain [16–18]. Future
studies should aim to identify the protease(s) responsible for
cleavage of annexin I in pre-apoptotic cells, following brief
cross-linking of Fas/APO-1.
Cytotoxic T lymphocytes (CTL) rapidly destroy their target
cells through induction of apoptosis. In fact, recent in vivo
studies have indicated that CTL start to eliminate adoptively
transferred target cells in mice within 15 min through a perfo-
rin-dependent mechanism [19]. Of note, the estimation of tar-
get cell killing in vivo is likely to be dependent not only on
killing itself but also on the phagocytic removal of killed target
cells. Therefore, these observations [19] suggest that CTL can
very rapidly induce alterations in the target cell that mark it
for phagocytic removal, even before cells are in the terminal
stages of apoptosis. The latter ﬁndings are in line with the cur-
rent observation that brief (15 min) cross-linking of Fas/APO-
1 is suﬃcient for macrophage clearance of target cells, and sug-
gest that clearance of pre-apoptotic cells may be a physiologi-
cally relevant event. For comparison, pioneering studies of the
developing nerve cord of Caenorhabditis elegans showed that
surrounding cells start to engulf cells that are programmed
to die almost immediately after birth of such cells at mitosis
[20].
To conclude, our studies show for the ﬁrst time that brief
cross-linking of Fas/APO-1 is suﬃcient to target Jurkat cells
and primary T cells for engulfment by activated human macro-
phages. In addition, we have shown that macrophages engulf-
ing pre-apoptotic cells produced signiﬁcantly lower levels of
the pro-inﬂammatory cytokine, TNF-a, and higher amounts
of IL-10, representative of anti-inﬂammatory cytokines. The
latter ﬁndings suggest that the uptake of pre-apoptotic cells
is a silent process and may contribute to the resolution of
inﬂammation.
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